NCT00003195
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Hemorrhagic Disorders
Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.
4,583 public trials
830 recruiting studies
Hemorrhagic Disorders trial results
NCT00478777
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Medizinische Klinik und Poliklinik II der Charité Universitätsmedizin Berlin Campus Mitte Berlin, Germany
- Poliklinik I, Hämatologie/ Onkologie, Universitätsklinikum Bonn Bonn, Germany
- Johanniter-Krankenhaus Bonn Friedrich-Wilhelm-Stift gGmbH Bonn, Germany
- Medizinische Klinik Städtisches Klinikum Braunschweig gGmbH Braunschweig, Germany
NCT00281476
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Completed
A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma
NCT00722566
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UZ Brussel Department Medical Oncology Laarbeeklaan 101 Brussels, Belgium
- Hôtel DIEU, Service D'Hématologie Place Alexis RICORDEAU Nantes, France
- Universitätsklinikum Münster Onkologische Ambulanz West Albert-Schweitzer-Str. 33 Münster, Germany
NCT00364182
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Chicago, Illinois, United States
- Pfizer Investigational Site Chicago, Illinois, United States
- Pfizer Investigational Site New Brunswick, New Jersey, United States
NCT00805051
- Conditions
- Aortic Stenosis, Aortic Valve Disease, Aortic Valve Stenosis, +19 more
- Locations
-
- Department of Anaesthesia, University of Basel Hospital Basel, Switzerland
Completed
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
NCT00562224
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
- Locations
-
- California Cancer Care Greenbrae, California, United States
- University of Chicago Chicago, Illinois, United States
- Sarah Cannon Research Institue Nashville, Tennessee, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00652041
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Hospital Morales Messeguer Murcia, Spain
- Hospital Virgen de la Vega Murcia, Spain
- Hospital de la Diputación de Navarra Navarra, Spain
- Hospital Clínico de Salamanca Salamanca, Spain
NCT00443235
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hospital Royo Villanova Zaragoza, Aragon, Spain
- Complejo Hospitalario Universitario de Albacete Albacete, Spain
- Fundación Hospital Alcorcón Alcorcón, Spain
- Hospital Nuestra Señora de Sonsoles Ávila, Spain
Completed
Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma
NCT00504634
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States